BioLife Solutions to Participate in Upcoming Investor Conferences in November and December 2025
BioLife Solutions to Participate in Upcoming Investor Conferences in November and December 2025 |
| [17-November-2025] |
BOTHELL, Wash., Nov. 17, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market, today announced that management will participate in the following investor conferences during November and December:
The BioLife Solutions Investor Presentation, reflecting the recently refreshed corporate branding, is now available on the Investor Relations section of the company's website. About BioLife Solutions BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X. Media & Investor Relations At the Company Investors
SOURCE BioLife Solutions, Inc. | ||
Company Codes: Nasdaq:BLFS,NASDAQ:BLFS |
View original content to download multimedia:
